NCT00554762View on ClinicalTrials.gov

Dose Response and Efficacy of GW842166 in Pain

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Healthy Subjects

Interventions

DRUG

GW842166X

Administer

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY